Search results
Results for “BPC-157”
Check each result's review status before you open it.
Tip: press / to focus. Press Esc to clear.
What do the evidence levels mean?
These labels give a quick guide. Established means strong evidence supports one defined use. Emerging means studies in people exist, but important questions remain. Insufficient means reliable studies in people are missing or too limited.
16 results for “BPC-157”
Exact names come first.Start with the full review for this peptide.
Read the review →BPC-157
Cell and animal studies, plus small early studies in people, do not prove that BPC-157 heals injuries in people.
“BPC-157 improves tendon healing in preclinical models.”
Cell and rat tendon studies report positive healing signals. The scope matters: these results support biological plausibility, not a proven human treatment.
“BPC-157 heals tendons and muscles in people.”
Early human work is too small and limited to establish efficacy. Reliable, replicated human outcome evidence is still needed.
“Athletes can use it because it is not a steroid.”
The 2026 WADA Prohibited List places BPC-157 in S0 non-approved substances, which is prohibited at all times for covered athletes. Whether it is a steroid is irrelevant to that status.
July 2026 PCAC briefing on BPC-157-related bulk drug substances
U.S. Food and Drug Administration · FDA review · 2026
Certain bulk drug substances for use in compounding that may present significant safety risks
U.S. Food and Drug Administration · Regulatory · 2026
BPC-157 as an investigational peptide therapeutic: translational development barriers
PubMed · Pharmaceutics · Science review · 2026
Safety of intravenous infusion of BPC157 in humans: a pilot study
PubMed · Alternative Therapies in Health and Medicine · Human pilot · 2025
Promoting effect of BPC 157 on tendon healing: tendon outgrowth, cell survival, and migration
PubMed · Journal of Applied Physiology · Preclinical · 2011
2026 prohibited list
World Anti-Doping Agency · Anti-doping · 2026
BPC 157 for acute hamstring muscle strain repair
ClinicalTrials.gov · Trial registry · 2026
BPC-157 side effects: what human studies do and do not show
A plain-language guide to BPC-157 safety. Current reports do not show which side effects occur or how often. It explains the small human record, FDA concerns, product risks, and what remains unknown.
Peptides for muscle growth: human evidence
Do peptides build muscle? Read what human studies found for CJC-1295, ipamorelin, tesamorelin, BPC-157, TB-500, PEG-MGF, and collagen peptides.
Are peptides legal? What U.S. law and the FDA actually say
No single legal status covers peptides. See which peptide medicines are approved, which can be compounded, what FDA Category 2 means, and where the rules stop.
Oral peptides: do peptide pills work?
Most oral peptides break down when swallowed. See which FDA-approved peptide pills are built to work, what their studies measured, and how to check a peptide pill claim.
KPV peptide: what it is, what the studies tested, and where FDA review stands
KPV peptide is a three-amino-acid piece of alpha-MSH. See what cell and animal studies tested, plus FDA's 2026 review and committee vote.